Biomaterials controlling the fate of MSCs represent a novel strategy in regenerative medicine.
Cationic polymers can modulate the differentiation of MSCs via ephrinB2/EphB4 signaling.
pHM3 compromises the osteocyte differentiation altering ephrinB2/EphB4 interaction.